Fosun joins Aurobindo, PE firms in final bids for Novartis’ $2B U.S. generics assets: report
admin 11th May 2018 Uncategorised 0India’s Aurobindo, China’s Fosun Pharma and private equity firms Apollo Global Management and CVC Capital Partners have all been identified as final bidders for some of Norvartis’ U.S. generics assets.
More: Fosun joins Aurobindo, PE firms in final bids for Novartis’ B U.S. generics assets: report
Source: fierce